ストックスクリーナーアプリを入手
98.15
1.45%
1.40
前日終値:
$96.75
開ける：
$97.2
24時間の取引高:
858.14K
Relative Volume:
0.62
時価総額：
$11.13B
収益：
$2.77B
当期純損益:
$286.61M
株価収益率:
41.77
EPS:
2.35
ネットキャッシュフロー:
$524.11M
1週間 パフォーマンス:
+1.45%
1か月 パフォーマンス:
-4.46%
6か月 パフォーマンス:
-2.73%
1年 パフォーマンス:
-12.37%
1日の値動き範囲:
$96.58
$98.32
1週間の範囲:
$96.47
$98.32
52週間の値動き範囲:
$81.36
$128.28
Revvity Inc Stock (RVTY) Company Profile
RVTY を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
98.15 | 10.97B | 2.77B | 286.61M | 524.11M | 2.35 |
|
TMO
Thermo Fisher Scientific Inc
|
592.51 | 217.70B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
230.40 | 161.70B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
669.99 | 54.02B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
137.95 | 38.58B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
225.37 | 38.39B | 15.90B | 1.28B | 2.21B | 7.2842 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-15 | ダウングレード | BofA Securities | Buy → Neutral |
| 2025-12-09 | 開始されました | Goldman | Neutral |
| 2025-10-16 | 開始されました | Guggenheim | Neutral |
| 2025-05-01 | アップグレード | UBS | Neutral → Buy |
| 2025-01-10 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2024-12-13 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-10-15 | アップグレード | Barclays | Equal Weight → Overweight |
| 2024-08-28 | 開始されました | Wells Fargo | Equal Weight |
| 2024-07-08 | 開始されました | Leerink Partners | Outperform |
| 2024-06-03 | 再開されました | Jefferies | Hold |
| 2024-01-16 | ダウングレード | UBS | Buy → Neutral |
| 2024-01-04 | アップグレード | Evercore ISI | In-line → Outperform |
| 2023-12-19 | 開始されました | Wells Fargo | Equal Weight |
| 2023-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2023-09-28 | 開始されました | Bernstein | Outperform |
| 2023-07-19 | 開始されました | Raymond James | Outperform |
| 2023-05-23 | 再開されました | Goldman | Buy |
すべてを表示
Revvity Inc (RVTY) 最新ニュース
Trading Systems Reacting to (RVTY) Volatility - Stock Traders Daily
Allspring Global Investments Holdings LLC Has $70.79 Million Stock Holdings in Revvity Inc. $RVTY - MarketBeat
Here’s Why Diamond Hill Mid Cap Composite Purchased Revvity (RVTY) in Q3 - Insider Monkey
Revvity Inc. (NYSE:RVTY) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Revvity Inc.: Quiet Re?Rating Story in a Volatile Diagnostics Market - AD HOC NEWS
Revvity, Inc. Faces Valuation Shift Amid Declining Sales and Rising Costs - Markets Mojo
Revvity Earnings Notes - Trefis
Can Revvity Inc. stock deliver strong annual returnsCandlestick Trading Patterns & Affordable Trading Growth - bollywoodhelpline.com
Revvity Inc. Stock Finds Its Footing as Investors Weigh Diagnostics Demand and AI Ambitions - AD HOC NEWS
Revvity Inc. Stock Price Live, Charts & News - The Economic Times
Revvity, Inc.'s (NYSE:RVTY) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue? - 富途牛牛
Revvity advances AI-driven scientific discovery with Signals Xynthetica - MSN
Q3 Earnings Highlights: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
(RVTY) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Did Revvity’s New AI Discovery Platform (RVTY) Quietly Redefine Its Innovation Moat? - simplywall.st
Revvity introduces AI-augmented design platform for molecular and materials discovery - BioSpectrum India
Aug Patterns: How Revvity Inc stock reacts to global recession fearsJuly 2025 Summary & Safe Capital Growth Trade Ideas - moha.gov.vn
Is Revvity Inc. stock a defensive play in 2025Global Markets & Stepwise Trade Signal Implementation - Улправда
How cyclical is Revvity Inc. stock compared to rivalsJuly 2025 Price Swings & Comprehensive Market Scan Reports - DonanımHaber
Revvity Advances AI-Driven Scientific Discovery With Signals Xynthetica - TradingView — Track All Markets
Will Revvity Inc. stock reach all time highs in 2025Weekly Trade Report & Expert Verified Stock Movement Alerts - DonanımHaber
Raymond James reiterates Outperform rating on Revvity stock after site visit - Investing.com Nigeria
Raymond James reiterates Outperform rating on Revvity stock after site visit By Investing.com - Investing.com India
What consensus target says about Revvity Inc. stockRate Cut & AI Optimized Trade Strategies - DonanımHaber
Why Revvity Inc. stock could outperform in 2025Weekly Profit Analysis & Precise Buy Zone Tips - DonanımHaber
Will Revvity Inc. stock benefit from automationJuly 2025 Closing Moves & Technical Buy Zone Confirmations - Улправда
Is Revvity Inc. stock a buy on dipsWeekly Trading Summary & Daily Price Action Insights - Улправда
What analyst consensus says on Revvity Inc. stockInsider Selling & Proven Capital Preservation Tips - Улправда
Revvity (BSP:R1VT34) EV-to-OCF : 22.14 (As of Dec. 18, 2025) - GuruFocus
Will Revvity Inc. stock see PE expansionMarket Activity Summary & High Conviction Buy Zone Picks - ulpravda.ru
Revvity to Present at J.P. Morgan Healthcare Conference - Business Wire
Does Revvity (NYSE:RVTY) Have A Healthy Balance Sheet? - simplywall.st
How is Revvity's stock performance compared to other health care stocks? - MSN
Revvity (NYSE: RVTY) officer disposes 25 shares for RSU tax withholding - Stock Titan
3 Reasons RVTY is Risky and 1 Stock to Buy Instead - The Globe and Mail
Revvity unveils AI-powered Signals Xynthetica to accelerate molecular and materials design - Indian Pharma Post
Revvity Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Revvity to launch AI models-as-a-service for scientific discovery - Investing.com Nigeria
Revvity Introduces Signals Xynthetica, an AI-Augmented Design Platform for Molecular and Materials D - PharmiWeb.com
Revvity Introduces New AI Service for Molecular, Materials Design - marketscreener.com
Revvity, Inc. Introduces Signals Xynthetica, an AI-Augmented Design Platform for Molecular and Materials Discovery - marketscreener.com
Barclays Maintains Revvity (RVTY) Overweight Recommendation - Nasdaq
Revvity Inc. stock underperforms Monday when compared to competitors - MarketWatch
Revvity Shares Fall After BofA Downgrade - marketscreener.com
Revvity stock rating downgraded to Neutral by BofA Securities - Investing.com South Africa
Revvity (NYSE:RVTY) Lowered to "Neutral" Rating by Bank of America - MarketBeat
Barclays Adjusts Price Target on Revvity to $115 From $105, Maintains Overweight Rating - marketscreener.com
Revvity Inc (RVTY) 財務データ
収益
当期純利益
現金流量
EPS
2.43%
0.11%
大文字化:
|
ボリューム (24 時間):